Financials

News Discussions Technicals Forecast Seasonals

4592 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

SanBio Co., Ltd. engages in the development, production and sale of regenerative cells medicines. It provides regenerative therapies for neurological disorders that include stroke, traumatic brain injury, eye diseases, and Parkinson's disease. The company was founded on February 27, 2013 and is headquartered in Tokyo, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

4592 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company